Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actavis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

Actavis

Kythera bags FDA approval for double chin therapy

Kythera bags FDA approval for double chin therapy That potential has raised speculation in the past that Kythera may find itself the subject of a takeover attempt, perhaps from Botox manufacturer Allergan (now part of Actavis) or another specialty

Medius Deal Watch table for February 2015

Medius Deal Watch table for February 2015 Acquisition - business units. 800. Actavis/ AstraZeneca. Respiratory medicines. Acquisition - business unit.

Actavis makes two additions to board of directors

Actavis makes two additions to board of directors Michael R Gallagher and Peter J McDonnell join. Actavis has elected Michael R Gallagher and Peter J McDonnell to its board of directors. ... Both Gallagher and McDonnell are former members of the board of directors for Allergan, whom Actavis completed

Actavis completes $70.5bn Allergan acquisition

Actavis completes $70.5bn Allergan acquisition Finalisation comes after bidding war with deal-hungry Valeant.  . Actavis has completed its acquisition of Allergan for a total value of around $70.5bn. ... The combination enhances Actavis' international commercial opportunities, with its commercial

Valeant raises offer for Salix; rival Endo bows out

Valeant raises offer for Salix; rival Endo bows out as a takeover prospect by Allergan, which eventually decided to link up instead with Actavis.

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE
The art of delivering valuable customer journeys aligned to your key messages in 2020...
DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...

Infographics